As you said, ACUS tried to rally a little today after it announced that data from its PIII 3 RAMP-1 & RAMP-2,which were presented AHA meeting in Orlando, showed that its Imagify Perfusion Stress Echo is effective & well-tolerated, minimally invasive & is the first echocardiography imaging able to assess myocardial perfusion. That of course, would have many potential benefits over nuclear stress testing, including faster results, lower cost and no exposure to radioactivity.
ACUS claims that data from the PIII,in which > 1,000 patients were evaluated showed that its system is superior to standard stress echocardiography & is as accurate as nuclear stress testing. (I guess I better check that with one of my sons.<g>)
The stock rally kind of floundered as the stock was up only $0.02 for the day & that was erased AHs.<g>
bigcharts.marketwatch.com
It had some upticks at 9:46AM on the one minute volume of 20,700 & traded as H as $1.56 but the price faded rather steadily & it closed near its intraday L. Today's volume of 622Ks was almost 3x its ADV, but less than the 872Ks traded on Oct 8,which was a down day.
bigcharts.marketwatch.com;
ACUS has been trimming its loss in the last 4Qs in spite of lower revenues,but the 2ndQ (June) revenues were better than in 2006. The EL for 2007 is around $1.30 vs. the $1.93 in 2006 & for 2008 the loss is expected to be cut to around $1.(Of course those estimates can change fast if its IPSE gets approved & the cardiologists start using it.)
The Oct 2003 H was around 16.25 There was some insider buying in May & the stock is trying to build a base at the $1.30 level since August.
bigcharts.marketwatch.com
Bernard
|
